Literature DB >> 6771867

Eradication of poliomyelitis in the United States. II. Experience with killed poliovirus vaccine.

D Salk.   

Abstract

Killed poliovirus vaccine was the only poliomyelitis vaccine available in the United States from 1954 to 1962. During that time, the incidence of poliomyelitis among non-vaccinated individuals decreased by 90%, an indication that the circulation of wild poliovirus had been reduced ("herd effect"). The rate of decline of wild poliovirus disease, which resulted from use of killed vaccine, did not change after oral, live poliovirus vaccine was introduced in 1962. Neither mass immunization campaigns nor use of an orally administered vaccine has increased rates of poliomyelitis immunization. Outbreaks of poliomyelitis can occur in susceptible subgroups in otherwise well vaccinated populations; therefore, the degree of population protection is best evaluated in terms of the number of susceptible individuals and their opportunities for contact with each other rather than in terms of the percentage of the total population vaccinated. Eradication of poliomyelitis and elimination of poliovirus from large populations are possible with use of killed poliovirus vaccine.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6771867     DOI: 10.1093/clinids/2.2.243

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  5 in total

1.  Failure to detect infection by oral polio vaccine virus following natural exposure among inactivated polio vaccine recipients.

Authors:  H E Gary; B Smith; J Jenks; J Ruiz; W Sessions; J Vinje; M Sobsey
Journal:  Epidemiol Infect       Date:  2007-03-22       Impact factor: 2.451

2.  Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.

Authors:  G B Pier; G Meluleni; J B Goldberg
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

3.  Polio immunization policy in the United States: a new challenge for a new generation.

Authors:  D Salk
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

4.  Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks.

Authors:  A R Hinman; J P Koplan; W A Orenstein; E W Brink; B M Nkowane
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

Review 5.  Eradicating polio in Pakistan: an analysis of the challenges and solutions to this security and health issue.

Authors:  Shoaib Fahad Hussain; Peter Boyle; Preeti Patel; Richard Sullivan
Journal:  Global Health       Date:  2016-10-12       Impact factor: 4.185

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.